MITRO (Nanjing) Biotech Co., Ltd. is the first domestic molecular imaging contract research organization (MI-CRO) company. MITROprovides outsourcing service for new drug development by Radiolabeling and Molecular Imaging technology. MITRO provides integrated solutions, including drug screening, biodistribution,pharmacokinetics and pharmacodynamics. MITRO provides the translational research service from nude mice, rats, monkeys to human. MITRO focus on cancer, coronary heart disease, Alzheimer's disease, epilepsy, Parkinson disease, Rheumatoid arthritis, Diabetes, gene, stem cell research. PET molecular imaging which with the outstanding advantages of in vivo imaging, dynamic quantitative, self control and continuous observation can greatly shorten the drug development cycle, reduce the R&D cost, reduce the risk of failure, speed up the drug listing.